John M. Holliman III, Executive Chairman at Capstone Therapeutics Corp. (CAPS), bought 25,000 shares at $0.26 ($7K) on 2013-12-06, disclosed to the SEC on 2013-12-06.
Open-market purchase of $6k CAPS by Executive Chairman. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CAPS | BUY | 2008-12-18 | $5K | — | Filing → |
| OLGC | BUY | 2008-08-19 | $17K | — | Filing → |
| OLGC | BUY | 2008-03-13 | $18K | — | Filing → |